—
C+
C+ The full Closelook — membership. Open the C+ overview

Merck & Company Inc (MRK) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Merck & Company Inc

MRK in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Merck is a pharmaceutical and healthcare company that sells prescription medicines, vaccines and animal-health products worldwide. Its human-health portfolio includes the oncology drug Keytruda, vaccines such as Gardasil and ProQuad, and treatments across cardiology, infectious disease and diabetes. It also runs a separate animal-health business selling livestock and companion-animal medicines. Merck is based in Rahway, New Jersey, and has been listed since 1978.
Where it sits in the stack
Merck sits outside our AI build-out index; it belongs to the healthcare sleeve of our universe as a pharmaceutical manufacturer rather than a supplier to the compute stack.
Who it is priced against
Its industry classification places it with other large drug manufacturers; the comparison the market draws most often is with Pfizer.
Why Closelook tracks it
Merck is a Dow Jones Industrial Average constituent; it carries no Closelook score yet. The diary has quoted it once, in a Midday 10 note listing it among health-care names making new 52-week highs.
What the diary watches
Whether Keytruda's contribution to group revenue and the pace of new drug and vaccine approvals keep the earnings base broadening beyond that single product.

Merck & Company Inc (MRK) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: MRK news on the tape · index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for MRK, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 10 analyst actions on the wire · latest: price target by Berenberg, 2026-09-11

The Street on this name

Analyst actions and the latest print for MRK from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target Berenberg — target 137 Target set to $137 (-5.3% to spot) 2026-09-11
  • Price target Guggenheim — target 170 Target set to $170 (+13.1% to spot) 2026-09-08
  • Price target Wells Fargo — target 170 from 150 Target raised to $170 from $150 (+11.6% to spot) 2026-09-04

10 actions on the analyst wire since 2026-08-13: 10 target changes. Analyst wire → · Earnings wire →

Who it is priced against Drug Manufacturers - General · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General · US

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against MRK on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 2.31%, quarterly · last 0.85 USD on 2026-09-15

Dividends and capital return

What MRK pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 3.40 USD per share · a 2.31% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year +4.9% against the prior twelve months prior twelve months 3.24 USD per share
  • Last distribution 0.85 USD per share as the price series records it, within days of the ex-date 2026-09-15
  • By calendar year 2023: 0.77 USD (partial) · 2024: 3.12 USD · 2025: 3.28 USD · 2026: 2.55 USD to date first distribution recorded in the three-year window: 2023-12-14

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Merck & Company Inc (MRK)?

Merck & Company Inc trades as MRK on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-18.

Is MRK in a Closelook index?

Not currently — Merck & Company Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does MRK trade against its moving averages?

Uptrend stack intact: Trades +7.1% vs the 50-day and +22.8% vs the 200-day average, 6.2% below the 52-week high and +92.7% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Merck & Company Inc do?

Merck is a pharmaceutical and healthcare company that sells prescription medicines, vaccines and animal-health products worldwide. Its human-health portfolio includes the oncology drug Keytruda, vaccines such as Gardasil and ProQuad, and treatments across cardiology, infectious disease and diabetes. It also runs a separate animal-health business selling livestock and companion-animal medicines. Its industry classification places it with other large drug manufacturers; the comparison the market draws most often is with Pfizer.

Where does Merck & Company Inc sit in the AI build-out?

Merck sits outside our AI build-out index; it belongs to the healthcare sleeve of our universe as a pharmaceutical manufacturer rather than a supplier to the compute stack. Merck is a Dow Jones Industrial Average constituent; it carries no Closelook score yet. The diary has quoted it once, in a Midday 10 note listing it among health-care names making new 52-week highs.

Does Merck & Company Inc pay a dividend?

Merck & Company Inc has paid 3.40 USD per share over the last twelve months, paid quarterly, a trailing yield of 2.31% on the 2026-09-17 close; the last distribution recorded in the price series was 0.85 USD on 2026-09-15. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Merck & Company Inc recently?

The most recent analyst action on Merck & Company Inc on the Closelook wire is a price target by Berenberg on 2026-09-11 (target 137). 10 actions on the analyst wire since 2026-08-13: 10 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelook written about Merck & Company Inc?

Merck & Company Inc appears in 1 Closelook piece, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelook said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for MRK, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelook

Where MRK appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelook universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.